Can common supplements shield the heart from chemo damage?
NCT ID NCT07349459
Summary
This study aims to see if taking melatonin or vitamin D can protect the heart from damage in breast cancer patients receiving the chemotherapy drug doxorubicin. It will involve 90 female patients who are scheduled for this treatment. Researchers will compare the heart health of patients taking these supplements to see if they reduce the risk of heart problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOXORUBICIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta University
Tanta, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.